- Report
- February 2024
- 110 Pages
Global
From €4219EUR$4,750USD£3,661GBP
- Report
- March 2024
- 150 Pages
Global
From €3419EUR$3,850USD£2,967GBP
€4308EUR$4,850USD£3,738GBP
- Report
- January 2024
- 150 Pages
Global
From €3419EUR$3,850USD£2,967GBP
€4308EUR$4,850USD£3,738GBP
- Report
- August 2022
- 115 Pages
Global
From €3997EUR$4,500USD£3,468GBP
- Report
- May 2024
- 240 Pages
Global
From €4436EUR$4,995USD£3,850GBP
- Report
- October 2024
- 88 Pages
Global
From €3500EUR$4,221USD£3,143GBP
- Report
- January 2025
- 132 Pages
Global
From €844EUR$950USD£732GBP
- Book
- July 2023
- 304 Pages
- Book
- February 2019
- 480 Pages

Dengue is a mosquito-borne viral infection that is found in tropical and subtropical regions around the world. Infectious disease testing for dengue is used to diagnose the presence of the virus in a patient. Diagnostic tests for dengue include serological tests, such as enzyme-linked immunosorbent assays (ELISA) and rapid diagnostic tests (RDTs). These tests detect the presence of antibodies in the patient's blood, which indicate a current or past infection. Molecular tests, such as polymerase chain reaction (PCR) tests, are also used to detect the presence of the virus in the patient's blood.
There are a number of companies that offer dengue testing products and services. These include bioMérieux, Abbott, Bio-Rad, DiaSorin, and Hologic. Other companies, such as Alere, Becton Dickinson, and Cepheid, offer molecular testing products for dengue. Additionally, there are a number of companies that offer point-of-care testing products for dengue, such as Chembio Diagnostics and SD Biosensor. Show Less Read more